NYSE:EHC Encompass Health - EHC Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Encompass Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. $60.94 -0.45 (-0.73%) (As of 01/30/2023 12:00 AM ET) Add Compare Share Share Today's Range$60.78▼$61.6850-Day Range$55.86▼$62.6852-Week Range$44.33▼$74.61Volume562,274 shsAverage Volume619,030 shsMarket Capitalization$6.08 billionP/E Ratio22.40Dividend Yield0.98%Price Target$64.13 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Encompass Health MarketRank™ ForecastAnalyst RatingBuy3.17 Rating ScoreUpside/Downside5.2% Upside$64.13 Price TargetShort InterestHealthy2.58% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-0.71Upright™ Environmental ScoreNews Sentiment1.00Based on 5 Articles This WeekInsider TradingAcquiring Shares$100,046 Bought Last QuarterProj. Earnings Growth15.77%From $2.79 to $3.23 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.68 out of 5 starsMedical Sector86th out of 1,049 stocksHospitals Industry2nd out of 3 stocks 1.6 Analyst's Opinion Consensus RatingEncompass Health has received a consensus rating of Buy. The company's average rating score is 3.17, and is based on 5 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $64.13, Encompass Health has a forecasted upside of 5.2% from its current price of $60.94.Amount of Analyst CoverageEncompass Health has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.58% of the float of Encompass Health has been sold short.Short Interest Ratio / Days to CoverEncompass Health has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Previous Next 1.7 Dividend Strength Dividend YieldEncompass Health has a dividend yield of 0.98%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthEncompass Health does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Encompass Health is 22.06%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Encompass Health will have a dividend payout ratio of 18.58% next year. This indicates that Encompass Health will be able to sustain or increase its dividend. Previous Next 5.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreEncompass Health has received a 84.38% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Private occupational therapy services", "Private rehabilitation services for the elderly", and "Private speech therapy services" products. See details.Environmental SustainabilityThe Environmental Impact score for Encompass Health is -0.71. Previous Next 2.8 News and Social Media Coverage News SentimentEncompass Health has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Encompass Health this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for EHC on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Encompass Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Encompass Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,046.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of Encompass Health is held by insiders.Percentage Held by Institutions96.14% of the stock of Encompass Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Encompass Health are expected to grow by 15.77% in the coming year, from $2.79 to $3.23 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Encompass Health is 22.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.82.Price to Earnings Ratio vs. SectorThe P/E ratio of Encompass Health is 22.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 111.31.Price to Earnings Growth RatioEncompass Health has a PEG Ratio of 2.59. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioEncompass Health has a P/B Ratio of 2.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Encompass Health (NYSE:EHC) StockEncompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984, and is headquartered in Birmingham, AL.Read More Receive EHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter. Email Address EHC Stock News HeadlinesJanuary 23, 2023 | americanbankingnews.comBrokerages Set Encompass Health Co. (NYSE:EHC) Price Target at $64.13January 20, 2023 | finance.yahoo.comLocal health care service provider to build Rhode Island hospitalJanuary 30, 2023 | Investing Trends (Ad)Profit From the Commercial Solar Boom?Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered. January 17, 2023 | finance.yahoo.comAlabama's Encompass Health to build Rhode Island rehab hospitalJanuary 16, 2023 | finance.yahoo.comEncompass Health's (EHC) Plan Marks Entry in Rhode IslandJanuary 16, 2023 | msn.comEncompass Health to build a 50-bed inpatient rehabilitation hospital in Rhode IslandJanuary 13, 2023 | finance.yahoo.comEncompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Johnston, Rhode IslandDecember 13, 2022 | seekingalpha.comTracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2022 UpdateJanuary 30, 2023 | Investing Trends (Ad)Profit From the Commercial Solar Boom?Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered. December 8, 2022 | finance.yahoo.com245-year-old Concordville Inn to be acquired, converted into health care facilityDecember 2, 2022 | finance.yahoo.comHealth care giant Encompass growing to meet needsNovember 24, 2022 | finance.yahoo.comIs Encompass Health (EHC) a Smart Lon-Term Investment?November 24, 2022 | finance.yahoo.comIs Encompass Health Corporation (NYSE:EHC) A High Quality Stock To Own?November 23, 2022 | seekingalpha.comEncompass Health: No Change To Buy Rating After Guidance DeltaNovember 21, 2022 | finance.yahoo.comEncompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Daytona Beach, FloridaNovember 8, 2022 | finance.yahoo.comWhy Is Encompass Health (EHC) Up 7.5% Despite Q3 Earnings Miss?November 2, 2022 | finance.yahoo.comInsiders purchases in Encompass Health Corporation (NYSE:EHC) last year yet to pay off, remain down US$11k despite recent gainsOctober 30, 2022 | seekingalpha.comEncompass Health Corporation (EHC) Q3 2022 Earnings Call TranscriptOctober 25, 2022 | benzinga.comPreview: Encompass Health's EarningsOctober 17, 2022 | finance.yahoo.comWorkspace Property Trust working to add rehabilitation hospital at Horsham business parkOctober 16, 2022 | finance.yahoo.comEncompass Health (NYSE:EHC) shareholders have endured a 11% loss from investing in the stock a year agoOctober 12, 2022 | msn.comMarijuana Stock Movers For October 12, 2022October 6, 2022 | nasdaq.comEncompass Health (NYSE:EHC) Takes On Some Risk With Its Use Of DebtOctober 6, 2022 | finance.yahoo.comEncompass Health named to Modern Healthcare's 'Best Places to Work in Healthcare' for 2022October 5, 2022 | finance.yahoo.comEncompass Health and Piedmont announce plans to build a 40-bed inpatient rehabilitation hospital in Athens, GeorgiaOctober 1, 2022 | msn.comBusiness Notebook: New CEO leads Encompass Health Rehab Hospital in AbileneSeptember 26, 2022 | finance.yahoo.comEncompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in The Villages, FloridaSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive EHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter. Email Address EHC Company Calendar Last Earnings10/27/2021Ex-Dividend for 1/17 Dividend12/30/2022Dividend Payable1/17/2023Today1/30/2023Next Earnings (Confirmed)2/07/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Hospitals Sub-IndustryHealth Care Facilities SectorMedical Current SymbolNYSE:EHC CUSIP42192430 CIK785161 Webwww.healthsouth.com Phone(205) 967-7116Fax205-969-4719Employees43,400Year Founded1984Price Target and Rating Average Stock Price Forecast$64.13 High Stock Price Forecast$72.00 Low Stock Price Forecast$58.00 Forecasted Upside/Downside+5.2%Consensus RatingBuy Rating Score (0-4)3.17 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)$2.72 Trailing P/E Ratio22.40 Forward P/E Ratio21.84 P/E Growth2.59Net Income$412.20 million Net Margins5.39% Pretax Margin10.32% Return on Equity15.59% Return on Assets5.33% Debt Debt-to-Equity Ratio1.59 Current Ratio1.21 Quick Ratio1.21 Sales & Book Value Annual Sales$5.12 billion Price / Sales1.19 Cash Flow$6.86 per share Price / Cash Flow8.88 Book Value$23.69 per share Price / Book2.57Miscellaneous Outstanding Shares99,790,000Free Float97,094,000Market Cap$6.08 billion OptionableOptionable Beta1.02 Social Links Key ExecutivesMark J. TarrPresident, Chief Executive Officer & DirectorDouglas E. ColtharpChief Financial Officer & Executive Vice PresidentElissa Joy CharbonneauChief Medical OfficerJohn Patrick DarbySecretary, Executive VP & General CounselAndrew L. PriceChief Accounting Officer & Senior Vice PresidentKey CompetitorsSelect MedicalNYSE:SEMEnvistaNYSE:NVSTElanco Animal HealthNYSE:ELANGrifolsNASDAQ:GRFSDoximityNASDAQ:DOCSView All CompetitorsInsiders & InstitutionsSumitomo Mitsui Trust Holdings Inc.Bought 26,810 shares on 1/30/2023Ownership: 1.342%International Assets Investment Management LLCBought 121,867 shares on 1/30/2023Ownership: 0.122%New York State Teachers Retirement SystemBought 2,902 shares on 1/27/2023Ownership: 0.065%Rice Hall James & Associates LLCSold 1,195 shares on 1/27/2023Ownership: 0.043%State of Michigan Retirement SystemBought 300 shares on 1/27/2023Ownership: 0.025%View All Insider TransactionsView All Institutional Transactions EHC Stock - Frequently Asked Questions Should I buy or sell Encompass Health stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" EHC shares. View EHC analyst ratings or view top-rated stocks. What is Encompass Health's stock price forecast for 2023? 6 brokerages have issued 12-month price targets for Encompass Health's stock. Their EHC share price forecasts range from $58.00 to $72.00. On average, they expect the company's stock price to reach $64.13 in the next twelve months. This suggests a possible upside of 4.6% from the stock's current price. View analysts price targets for EHC or view top-rated stocks among Wall Street analysts. How have EHC shares performed in 2023? Encompass Health's stock was trading at $59.81 at the start of the year. Since then, EHC shares have increased by 2.5% and is now trading at $61.28. View the best growth stocks for 2023 here. Are investors shorting Encompass Health? Encompass Health saw a decrease in short interest in December. As of December 30th, there was short interest totaling 2,520,000 shares, a decrease of 8.4% from the December 15th total of 2,750,000 shares. Based on an average daily trading volume, of 684,500 shares, the short-interest ratio is presently 3.7 days. Approximately 2.6% of the shares of the company are short sold. View Encompass Health's Short Interest. When is Encompass Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 7th 2023. View our EHC earnings forecast. How can I listen to Encompass Health's earnings call? Encompass Health will be holding an earnings conference call on Wednesday, February 8th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link. How were Encompass Health's earnings last quarter? Encompass Health Co. (NYSE:EHC) released its quarterly earnings results on Wednesday, October, 27th. The company reported $1.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.06 by $0.03. The business had revenue of $1.28 billion for the quarter, compared to analysts' expectations of $1.31 billion. Encompass Health had a net margin of 5.39% and a trailing twelve-month return on equity of 15.59%. The business's revenue for the quarter was up 9.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.78 EPS. How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health? Encompass Health announced a quarterly dividend on Wednesday, October 19th. Stockholders of record on Tuesday, January 3rd will be paid a dividend of $0.15 per share on Tuesday, January 17th. This represents a $0.60 dividend on an annualized basis and a yield of 0.98%. The ex-dividend date of this dividend is Friday, December 30th. Read our dividend analysis for EHC. Is Encompass Health a good dividend stock? Encompass Health (NYSE:EHC) pays an annual dividend of $0.60 per share and currently has a dividend yield of 0.98%. The dividend payout ratio is 22.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EHC will have a dividend payout ratio of 18.58% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for EHC. What guidance has Encompass Health issued on next quarter's earnings? Encompass Health issued an update on its FY 2022 earnings guidance on Wednesday, November, 2nd. The company provided EPS guidance of $2.71-$2.86 for the period, compared to the consensus earnings per share estimate of $2.86. The company issued revenue guidance of $4.32 billion-$4.35 billion, compared to the consensus revenue estimate of $4.36 billion. What is Mark Tarr's approval rating as Encompass Health's CEO? 231 employees have rated Encompass Health Chief Executive Officer Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among the company's employees. What other stocks do shareholders of Encompass Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Pfizer (PFE), Verizon Communications (VZ) and Advanced Micro Devices (AMD). What is Encompass Health's stock symbol? Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC." Who are Encompass Health's major shareholders? Encompass Health's stock is owned by many different institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (1.34%), Copeland Capital Management LLC (0.99%), Reinhart Partners Inc. (0.79%), Wedge Capital Management L L P NC (0.55%), Bernzott Capital Advisors (0.39%) and Fort Washington Investment Advisors Inc. OH (0.28%). Insiders that own company stock include Andrew L Price, Donald L Correll, Elissa Joy Charbonneau, Greg D Carmichael, Kevin J O'connor, Mark J Tarr and Terrance Williams. View institutional ownership trends. How do I buy shares of Encompass Health? Shares of EHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Encompass Health's stock price today? One share of EHC stock can currently be purchased for approximately $61.28. How much money does Encompass Health make? Encompass Health (NYSE:EHC) has a market capitalization of $6.12 billion and generates $5.12 billion in revenue each year. The company earns $412.20 million in net income (profit) each year or $2.72 on an earnings per share basis. How many employees does Encompass Health have? The company employs 43,400 workers across the globe. How can I contact Encompass Health? Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The official website for the company is www.healthsouth.com. The company can be reached via phone at (205) 967-7116, via email at investorrelations@healthsouth.com, or via fax at 205-969-4719. This page (NYSE:EHC) was last updated on 1/30/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.